Schonfeld Strategic Advisors LLC Cabaletta Bio, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $15 Billion
- Q1 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 1,662,401 shares of CABA stock, worth $2.21 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,662,401Holding current value
$2.21 Million% of portfolio
0.02%Shares
4 transactions
Others Institutions Holding CABA
# of Institutions
86Shares Held
43MCall Options Held
154KPut Options Held
192K-
Jennison Associates LLC6.02MShares$8.01 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$6.33 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.97MShares$5.28 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$4.83 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.45MShares$4.59 Million0.0% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $38.6M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...